Clinical Effectiveness Of High Frequency Chest Wall Oscillation (HFCWO) In A Bronchiectasis Population

Completed

Conditions studied: Bronchiectasis

In brief

The primary objective is to compare the patient's baseline QoL prior to HFCWO use against the patient's QoL at various study timepoints over a one-year period of HFCWO use.

Key facts

Study ID

NCT04271969

Run by

Electromed, Inc.

People needed

25

Starts

2020-02-18

Expected to finish

2023-12-01

Last updated by the study team

2023-12-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Previous diagnosis of bronchiectasis confirmed by HRCT within the last 6 months
• Patients must have at least 6 months of medical records related to bronchiectasis
• Patients must be stable and currently on a standard of care regimen for bronchiectasis such as hypertonic saline and/or PEP
• Patients with 1 or more exacerbations within the last 12 months
• Previous and existing productive cough
• No previous HFCWO use

You may not qualify if…

• Patients who are known to have cystic fibrosis
• Patients who are known to have primary ciliary dyskinesia (PCD)
• Patients with chronic obstructive pulmonary disease (COPD) without bronchiectasis
• Patients breathing via an artificial airway
• Severe bronchospasm based on exam or history
• Any comorbidity(ies) or contraindications that would normally complicate tolerating HFCWO treatment

Where it is running

• University of Alabama - Birmingham (UAB University Hospital) — Birmingham, Alabama, United States
• Emory University School of Medicine — Atlanta, Georgia, United States
• Temple University — Philadelphia, Pennsylvania, United States
• The University of Texas Health Science Center at Tyler — Tyler, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.